DEUTSCHE BANK AG\ - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 25 filers reported holding SEELOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$36,507
+72.9%
30,5500.0%0.00%
Q1 2023$21,110
-50.4%
30,550
-51.2%
0.00%
Q4 2022$42,538
-34.6%
62,6480.0%0.00%
Q3 2022$65,000
+51.2%
62,6480.0%0.00%
Q2 2022$43,000
-4.4%
62,648
+17.5%
0.00%
Q1 2022$45,000
-53.6%
53,327
-10.6%
0.00%
Q4 2021$97,000
-28.7%
59,663
+5.6%
0.00%
Q3 2021$136,000
-81.8%
56,503
-80.0%
0.00%
Q2 2021$746,000282,683
+282583.0%
0.00%
Q2 2019$01000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
1492 Capital Management LLC 150,000$152,0000.13%
Spark Investment Management LLC 35,210$35,0000.13%
Uniplan Investment Counsel, Inc. 1,356,435$1,370,0000.10%
ARDSLEY ADVISORY PARTNERS LP 80,000$81,0000.02%
Virtu Financial LLC 96,359$97,0000.01%
K.J. Harrison & Partners Inc 20,000$20,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 181,500$183,0000.00%
Procyon Advisors, LLC 5,000$5,0000.00%
WealthPLAN Partners, LLC 20,000$21,0000.00%
CIBC WORLD MARKET INC. 300,000$303,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders